ARCHIVES

Also C-Change new name for National Dialogue on Cancer.

This article is from The Cancer Letter archive.

Vol. 30 No. 03 | January 16, 2004

Download PDF Visit The Full Archive

Related Articles

With Flashing Lights, Heckling, and Folk Song, Avastin Sets New Tone for FDA Debates

July 1, 2011

ACS Asks Higher NCI Authorization

March 24, 1978

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

ASCO Picks University of Michigan Medical School Dean Allen Lichter As Exective Vice President and CEO.

July 14, 2006

DCCR Community Oncology Program RFP Now Ready

April 27, 1979

Contracting Dispute and Software Bugs Plague NCI’s $200 Million Bioinformatics Venture

February 25, 2011